Unlike CD44 and CD133, the identification of tumor cells that express high levels of ALDH requires the use of the non-immunologic enzymatic ALDEFLUORTM Kit and FACS (Chen et al., 2009; Huang et al., 2009; Clay et al., 2010). This evidence concerns the gene CD44 and neoplasm.